The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RAS/BRAF testing of circulating cell-free DNA (cfDNA) in RAS/BRAF wild-type (RAS/BRAFWT) metastatic colorectal cancer (mCRC) patients: Preliminary results of the phase III LIBImAb study.
 
Anna Maria Rachiglio
No Relationships to Disclose
 
Angela Damato
Travel, Accommodations, Expenses - Incyte; Ipsen; Janssen-Cilag; Lilly
 
Cecilia Silvestri
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Alessio Aligi Cogoni
No Relationships to Disclose
 
Alessandro Passardi
No Relationships to Disclose
 
Livio Blasi
No Relationships to Disclose
 
Stefania Mosconi
No Relationships to Disclose
 
Chiara Carlomagno
No Relationships to Disclose
 
Alfredo Colombo
No Relationships to Disclose
 
Stefano Tamberi
Consulting or Advisory Role - AstraZeneca; Seagen; Takeda
Speakers' Bureau - AstraZeneca
 
Roberto Bordonaro
No Relationships to Disclose
 
Ferdinando Riccardi
No Relationships to Disclose
 
Gerardo Rosati
No Relationships to Disclose
 
Michele Ghidini
No Relationships to Disclose
 
Stamatia Zampiri
No Relationships to Disclose
 
Maura Rossi
No Relationships to Disclose
 
Erika Gerasi
No Relationships to Disclose
 
Ilenia La Grotteria
No Relationships to Disclose
 
Nicola Normanno
Honoraria - Amgen; AstraZeneca; Biocartis; Illumina; Incyte; Lilly; Merck Serono; MSD; MSD; Novartis; Novartis; SERVIER; SOPHiA Genetics; Thermo Fisher Scientific
Consulting or Advisory Role - AstraZeneca; Bayer; Biocartis; Incyte; Novartis; Roche
Research Funding - AstraZeneca (Inst); Biocartis (Inst); Illumina (Inst); Incyte (Inst); Merck Serono (Inst); Qiagen (Inst); Roche (Inst); SOPHiA Genetics (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Merck Serono
 
Carmine Pinto
No Relationships to Disclose